Maya Martinez-Davis
Maya joined the Executive Committee in 2026. She is President, US and leads GSK’s US business, driving sustainable revenue and profit growth across all therapeutic areas. She joined GSK in 2019.
Prior to GSK, Maya was President, Biopharma Latin America and Global Head of Oncology Franchise at Merck KGaA, and Regional President, Oncology North America at Pfizer.
She is an Independent Director at Perspective Therapeutics.
Maya holds a Bachelor’s degree from Saint Louis University and a Master’s in Commercial Management and Marketing from IE Business School, Madrid.
